2020
DOI: 10.1007/s12265-020-09977-4
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic and Prognostic Value of Coronary Computed Tomography Angiography in Patients with Severe Calcification

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…The diagnostic performance of CCTA was evaluated in multiple studies with a correlation to CACS [17][18][19]. Not only the diagnostic performance of CCTA was studied, but also its prognostic value which has been proven in different studies [20,21]. However, evaluation of CACS (rather than the CCTA) as the primary diagnostic tool at multiple low and high cutoff levels for the detection of significant coronary stenosis (at two different cutoffs of 50 and 70%) in a large number of symptomatic patients was not previously investigated in one study.…”
Section: Introductionmentioning
confidence: 99%
“…The diagnostic performance of CCTA was evaluated in multiple studies with a correlation to CACS [17][18][19]. Not only the diagnostic performance of CCTA was studied, but also its prognostic value which has been proven in different studies [20,21]. However, evaluation of CACS (rather than the CCTA) as the primary diagnostic tool at multiple low and high cutoff levels for the detection of significant coronary stenosis (at two different cutoffs of 50 and 70%) in a large number of symptomatic patients was not previously investigated in one study.…”
Section: Introductionmentioning
confidence: 99%
“…This study employs computational screening methodology and functional studies to investigate niclosamide as a vascular calcification inhibitor. Vascular calcification is closely associated with many major adverse cardiovascular events ( 3 ). This publication utilizes drug repositioning strategy to identify novel therapeutic applications of existing drugs, thereby reducing time and cost compared to the traditional de novo drug discovery ( 4 ).…”
mentioning
confidence: 99%